Bioelectronics Corp (BIEL)

[Simpsonly]

went to > $ .12 in 2009 (?) on relatively little news, mostly hype - FDA approval would be a different story, but company has to go thru the journey first. Whoever would have guessed that the FDA would wrongly classify ALLAY recently?

Get the diplomats heavily involved rather than the logical business executives, so the FDA decision makers and their bosses can save face - key issue. There's gonna be a hero here, a Senator, or an Inspector General, or an FDA executive, but allow whoever is responsible for the snafu to save face and let's get on with the obvious.